Literature DB >> 20101546

Venous thromboembolic disease in the intensive care unit.

Chee M Chan1, Andrew F Shorr.   

Abstract

Critically ill patients are at increased risk of developing venous thromboemboli (VTE). Risk factors that predispose them to acquiring VTE encompass factors that usually afflict the general medical population as well as factors attained in the intensive care unit (ICU) (e.g., sedation, mechanical ventilation). The poor cardiopulmonary reserve of this patient population is intolerant of even small pulmonary emboli (PE), which emphasizes the importance of preventing VTE from ever occurring. Indeed, the complications associated with hospital-acquired VTE increase morbidity, mortality, hospital length of stay, and costs. Without thromboprophylaxis, the incidence of VTE in the ICU ranges from 15 to 60%. Systematic implementation of VTE prophylaxis significantly reduces this rate and as a consequence, morbidity and mortality. In fact, prevention of VTE is so important that the American College of Chest Physicians (ACCP) developed guidelines on the use of routine VTE prophylaxis in critically ill patients. Therefore, upon admission, all ICU patients should be evaluated for and immediately prescribed the appropriate thromboprophylaxis therapy. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20101546     DOI: 10.1055/s-0029-1246283

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  7 in total

1.  The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation.

Authors:  J P Singer; P D Blanc; C Hoopes; J A Golden; J L Koff; L E Leard; S Cheng; H Chen
Journal:  Am J Transplant       Date:  2011-08-10       Impact factor: 8.086

2.  Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients.

Authors:  Ena Gupta; Furqan S Siddiqi; Ryan Kunjal; Muhammad Faisal; Farah Al-Saffar; Abubakr A Bajwa; Lisa M Jones; Vandana Seeram; James D Cury; Adil Shujaat
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

3.  Computer surveillance of patients at high risk for and with venous thromboembolism.

Authors:  R Scott Evans; James F Lloyd; Valerie T Aston; Scott C Woller; Jacob S Tripp; C Greg Elliott; Scott M Stevens
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

4.  A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial.

Authors:  Sian Robinson; Aleksander Zincuk; Ulla Lei Larsen; Claus Ekstrøm; Palle Toft
Journal:  Trials       Date:  2014-06-13       Impact factor: 2.279

5.  Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?

Authors:  Mohan Gurjar
Journal:  Indian J Crit Care Med       Date:  2014-06

Review 6.  Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.

Authors:  Marcello Di Nisio; Ettore Porreca
Journal:  Drug Des Devel Ther       Date:  2013-09-16       Impact factor: 4.162

7.  A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial.

Authors:  Sian Robinson; Aleksander Zincuk; Ulla Lei Larsen; Claus Ekstrøm; Mads Nybo; Bjarne Rasmussen; Palle Toft
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.